Calviri

Phoenix, United States · Founded 2017 · $2.5M raised

Headquarters
Phoenix, Arizona
Founded
2017
Total Funding
$2.5M
Last Round
$2.3M SeedApr 2020
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Calviri was formed in Phoenix, Arizona in 2017 to end cancer, built on the discovery of an unappreciated, fundamental molecular characteristic of all tumors that distinguishes them from healthy host cells. The company invented technologies that merge biology with semiconductor chips to create diagnostics and vaccines. Calviri is now commercializing its canine multi-cancer test, and is in trial with an early-stage canine therapeutic vaccine to treat cancer, with human products planned to follow.

Summary

Calviri is a Biotech company based in Phoenix, United States, founded in 2017. It has raised $2.5M in total across 2 rounds, most recently a $2.3M Seed round in Apr 2020.

Funding History

SeedSeed RoundApr 2020
$2.3M

Sign up to see all 2 events

Funding: Grant through Seed. Amounts, valuations, and investors where available.

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Calviri on Indexed.vc
<a href="https://indexed.vc/companies/calviri"><img src="https://indexed.vc/api/badge/company/calviri" alt="Calviri on Indexed.vc" width="260" height="76" /></a>